Sulodexide Withdrawn Phase 1 Trials for Dense Deposit Disease Prevention

IndicationsStatusPurposePhase
WithdrawnPrevention1
clinicaltrials.gov IdentifierTitleDrugs
NCT00583427Sulodexide Treatment in Patients With Dense Deposit Disease